526445
vs
G
GCE
526445
G
GCE
Over the past 12 months, INDRANIB has underperformed GCE, delivering a return of -58% compared to the GCE's 5% drop.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
526445
GCE
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
INDRANIB
Intrinsic Value
23.2
INR
Undervaluation 65%
G
GCE
Intrinsic Value
0.28
MYR
Overvaluation 20%
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Indrayani Biotech Ltd
BSE:526445
|
8.17
INR
|
|||||
|
G
|
Grand Central Enterprises Bhd
KLSE:GCE
|
0.35
MYR
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
526445, GCE
526445, GCE
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Indrayani Biotech Ltd
Revenue
|
|||||||||||
|
G
|
Grand Central Enterprises Bhd
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
526445, GCE
526445, GCE
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Indrayani Biotech Ltd
BSE:526445
|
|||||||||
|
G
|
Grand Central Enterprises Bhd
KLSE:GCE
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
INDRANIB
28%
GCE
0%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Indrayani Biotech Ltd | ||||
|
G
|
Grand Central Enterprises Bhd | ||||
Operating Margin
INDRANIB
-1.1%
GCE
-25.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Indrayani Biotech Ltd | ||||
|
G
|
Grand Central Enterprises Bhd | ||||
Net Margin
INDRANIB
-5.3%
GCE
-22.3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Indrayani Biotech Ltd | ||||
|
G
|
Grand Central Enterprises Bhd | ||||
FCF Margin
INDRANIB
-11.3%
GCE
-16.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Indrayani Biotech Ltd | ||||
|
G
|
Grand Central Enterprises Bhd | ||||
ROE
INDRANIB
-9.4%
GCE
-3.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Indrayani Biotech Ltd | ||||
|
G
|
Grand Central Enterprises Bhd | ||||
ROA
INDRANIB
-2.7%
GCE
-3.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Indrayani Biotech Ltd | ||||
|
G
|
Grand Central Enterprises Bhd | ||||
ROIC
INDRANIB
-0.7%
GCE
-4.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Indrayani Biotech Ltd | ||||
|
G
|
Grand Central Enterprises Bhd | ||||
ROCE
INDRANIB
-0.8%
GCE
-4.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Indrayani Biotech Ltd | ||||
|
G
|
Grand Central Enterprises Bhd | ||||
Solvency Comparison
G
Grand Central Enterprises Bhd
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
526445, GCE
526445, GCE
Performance By Year
526445, GCE
526445, GCE
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 526445 to other stocks
HTHTN
H World Group Ltd
H
More expensive
vs INDRANIB
MAR
Marriott International I...
More expensive
vs INDRANIB
HLT
Hilton Worldwide Holding...
More expensive
vs INDRANIB
IHG
InterContinental Hotels...
More expensive
vs INDRANIB
Select Stock to Compare
| CN |
H
|
H World Group Ltd
BMV:HTHTN
|
|
| US |
|
Marriott International Inc
NASDAQ:MAR
|
|
| US |
|
Hilton Worldwide Holdings Inc
NYSE:HLT
|
|
| UK |
|
InterContinental Hotels Group PLC
LSE:IHG
|
|
| CN |
|
Huazhu Group Ltd
HKEX:1179
|
|
| US |
|
Hyatt Hotels Corp
NYSE:H
|
|
| ZA |
S
|
Southern Sun Ltd
JSE:SSU
|
|
| FR |
|
Accor SA
PAR:AC
|
|
| IN |
|
Indian Hotels Company Ltd
NSE:INDHOTEL
|
|
| SG |
|
City Developments Ltd
SGX:C09
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
